18 Aug, 2017, 11:22 ET
TOTOWA, N.J., Aug. 18, 2017 /PRNewswire/ -- BiologicTx®, a member of the BioMatrix SpRx family of companies, today announced that their kidney paired donation software, BiologicTx MatchGrid™, was the matching software utilized for a successful 9-way kidney exchange at the Yale New Haven Hospital beginning on May 9th and concluding on June 21st, 2017. The largest kidney exchange in Connecticut history included 9 donor and recipient pairs and was initiated by a non-directed donor (NDD).
BiologicTx Paired Donation's MatchGrid is an advanced enterprise software application that provides doctors and clinicians with the tools necessary to rapidly and accurately match living organ donors with patients who have willing, healthy, but incompatible donors. Using advanced matching and optimization algorithms, MatchGrid can evaluate all potential matches within a center in minutes, saving transplant centers months of work previously required to assess a smaller number of pairs. The software can also optimize the number of transplants for a given pool of donor/recipient pairs, ensuring the maximum number of transplants for the most difficult people to match, with the highest quality matches for each transplant in a paired kidney donation network.
"Many of these kidney transplants were quite complex and beyond the level of risk often taken by many transplant centers," said David Mulligan, MD, director, Yale New Haven Transplantation Center and professor of surgery at Yale School of Medicine. "Not only has it truly been a miracle for YNHTC to bring all these amazing pairs together, but it is also an example of the fantastic multidisciplinary team of doctors, nurses, social workers, dietitians, tissue typing lab, and OR staff that made each donor and recipient come through with flying colors."
"The success of the 9-way kidney exchange is a testament not only to the expertise of the clinicians at Yale New Haven Transplantation Center but also to the power of BiologicTx MatchGrid," stated David Jacobs, Chief Technology Officer at BiologicTx. "We built this application for centers like Yale New Haven to help them perform more kidney transplants in a shorter period of time. We are thankful to all the amazing donors and excited for all the recipients who are starting a new life post-transplant."
"Providing cutting edge digital health technology and unsurpassed clinical services is what BiologicTx does best," stated Todd Krasinsky, RN, Chief Development Officer, and Co-founder at BiologicTx. "We are both pleased and humbled to provide such powerful, lifesaving software to our patients and transplant centers,"
For additional information on BiologicTx MatchGrid, please visit www.BiologicTx.com/MatchGrid
BiologicTx®, a member of the BioMatrix SpRx family of companies, was founded as the first, solely focused infusion and pharmacy provider of biologic and oral transplant therapy management. Since then, BiologicTx has expanded its services to integrate transplant therapies paired with digital health technology, providing a complete representation of the patient's response to therapy. Our team is comprised of dedicated professionals that strive to advance desensitization, immunosuppressive, and rejection treatments worldwide, resulting in progressive and favorable patient outcomes. We deliver efficient, start to finish services that establish therapeutic services in the home and clinic. These services act in concert with the transplant center medical team. In doing so, we provide hope and a better quality of life to our patients. For more information, visit us at: www.BiologicTx.com.
About BioMatrix SpRx
BioMatrix SpRx offers comprehensive nationwide specialty pharmacy services and digital health technology solutions for a range of chronic health conditions. Our growing family of companies unites leaders in the specialty pharmacy industry to improve health and empower patients to experience a higher quality of life.
The current BioMatrix family of companies includes BiologicTx, Factor Support Network, Matrix Health, and Medex BioCare.
Share this article